Genetic Technologies Ltd (NASDAQ:GENE)
| 0.5985 Delayed Data As of Dec 06 |  0.00 / 0.00%Today’s Change | 0.56 Today|||52-Week Range 2.40 | -35.65% Year-to-Date |
Latest GENE News | Press Releases
No recent news for Genetic Technologies Ltd.
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.62 |
| Day’s range | 0.60 - 0.62 |
| Volume | 527 |
| Average volume (3 months) | 101,113 |
| Market cap | $14.0M |
Data as of 3:58pm ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | -39.76% |
| Earnings growth (this year) | +100.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +18.57% |
| P/E ratio | NM |
| Price/Sales | 2.40 |
| Price/Book | 1.51 |
Competitors
Data as of 3:58pm ET, 12/07/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $5.8M |
| Annual profit (last year) | -$7.9M |
| Net profit margin | -135.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Fitzroy, Victoria (vic) |
Forecasts
